Wed, Apr. 15, 11:34 AM
- On a preliminary basis, HCA Holdings (HCA +2.5%) expects Q1 revenues of $9.675B (+9.5%), pre-tax income of $1.075B (+58.1%); adjusted EBITDA of $1.960B (+19.2%) and EPS of $1.35 (+77.6%).
- Same facility admissions increased 5.1%, same facility equivalent admissions rose 6.8% and same facility emergency room visits rose 11.5%. Same facility revenue per equivalent admission is expected to increase 1.6%.
- Updated 2015 Guidance: Revenues: $39.0B - 40.0B from $38.5B - 39.5B; Non-GAAP EBITDA: $7.55B - 7.85B from $7.35B - 7.65B; Non-GAAP EPS: $4.90 - 5.30 from $4.55 - 4.95; CAPEX: ~$2.4B (unch).
- The company will report final Q1 results on or about May 5.
Wed, Apr. 1, 3:30 PM
- Actavis (ACT -1%) should outperform following its purchase of Allergan, and FDA action dates for eluxadoline and cariprazine could also be catalysts.
- Though Occidental Petroleum is the team's top pick in energy, Anadarko (APC +1.1%) is the best short-term play on a recovery in oil prices.
- Strong fundamentals and easy year-over-year comps make AvalonBay (AVB -0.9%) a pick in apartment rentals.
- A favorable Supreme Court ruling in King vs. Burwell by the end of June provides plenty of upside possibility with little downside for HCA Holdings (HCA -0.8%).
- Also on the buy list are Ingersoll-Rand (IR -1.5%), Nvidia (NVDA +0.2%), UTX (UTX -1.1%), and Disney (DIS +0.4%).
- Making the underperform list is the Gap (GPS -2.2%) thanks to less room for cost cutting and a forecast for continued weakness in sales. Also a Q2 sell: Tesla (TSLA -1%) " lacks any real technological advantage over its competitors" says the team, seeing a significant Q1 loss, an increase in the already-high cash burn, and a questionable delivery outlook.
- Source: Benzinga
Wed, Mar. 4, 7:21 PM
- Shares of hospital operators and some managed care providers turned in strong gains today after the U.S. Supreme Court entertained arguments on a case that questioned whether Obamacare health insurance subsidies should be provided in the 34 states that have not set up their own exchanges (transcript).
- The catalyst come from questions posed by Justice Kennedy - considered a swing vote on the issue - voicing concerns about potential constitutional consequences of a ruling that strikes down the availability of the subsidies.
- Kennedy said throwing out subsidies would potentially unlawfully pressure states and cause an insurance "death spiral" because premiums would increase, but he also said he had an open mind over the challengers' interpretation of the law.
- CYH +6.3%, THC +6.2%, HCA +5.8%, LPNT +3.6%, EVHC +3.6%, UHS +2.7%, TMH +2%.
Wed, Mar. 4, 12:11 PM
- Hospitals rally on comments from Supreme Court Justice Anthony Kennedy, often a swing vote in important cases. He says there is a powerful point to the Obama administration's argument that the Affordable Care Act would fall apart if the subsidies were ruled invalid.
- The Court is currently hearing arguments in the case King v. Burwell, which challenges federal subsidies in states that did not create their own health insurance exchanges. Its final decision will not be announced until June, though.
- Hospitals and health insurers have the most at stake. They have benefited greatly since the law was signed in 2010. To date, 11.4M Americans have signed up for coverage in 2015, giving both groups more paying customers and potentially cutting the number of non-paying emergency room visits. If the subsidies were ruled invalid then many people would drop coverage due to the higher cost.
- Related tickers: (HCA +6.2%)(THC +5.4%)(UHS +2.6%)(CYH +5.4%)(LPNT +3.3%)(SEM -0.9%)(SSY)(HUM +0.1%)(CI -0.4%)(CNC)(MOH +0.3%)(ANTM +0.5%)(UNH +0.3%)(MGLN +0.3%)(WCG +0.3%)
Mon, Feb. 23, 12:07 PM
- Among the additions to the index (which fuels the IBLN ETF) are EMC, Google (GOOG, GOOGL), Goodyear (NASDAQ:GT), Mohawk Industries (NYSE:MHK), PVH, Time Warner (NYSE:TWX), and Yahoo (NASDAQ:YHOO). There are three health care additions as well: Allergan (NYSE:AGN), Amgen (NASDAQ:AMGN), and HCA. The lone energy name added is Consol Energy (NYSE:CNX).
- Exiting the index are energy names Halliburton (NYSE:HAL) and National-Oilwell Varco (NYSE:NOV), along with healthcare companies AbbVie (NYSE:ABBV), Aetna (NYSE:AET), Humana (NYSE:HUM), and Tenet Healthcare (NYSE:THC). Citigroup (NYSE:C), CBS, Crown Castle (NYSE:CCI), and Michael Kors (NYSE:KORS) round out those subtracted.
- IBLN tracks the highest-conviction S&P 500 picks by hot-handed billionaires who built their fortunes through hedge funds and investing. The list of billionaires tracked is updated each October, and the equity components are rebalanced each quarter after sifting through regulatory filings.
- IBillionaire Index Rebalance
Thu, Feb. 5, 9:04 AM
- Fourteen of 23 prominent hospitals contacted by Reuters have rolled out pilot programs of Apple's HealthKit service, which enables the remote monitoring of patient-generated health information, such as blood pressure, weight and heart rate, via an iPhone. The technology will potentially enable physicians detect early signs of trouble and to intervene accordingly in patients with chronic diseases like diabetes and hypertension before the situation becomes acute (and much more expensive).
- Google and Samsung have released similar services and have also begun to reach out to hospitals. This bodes well for patients and doctors alike.
- Related tickers: (NYSE:HUM) (NYSE:HCA) (NYSE:UHS) (NYSE:CYH) (NASDAQ:LPNT) (NYSE:SEM) (NYSE:ADPT) (NYSEMKT:SSY) (NYSE:THC)
Tue, Feb. 3, 8:59 AM
- HCA Holdings (NYSE:HCA) Q4 Results ($M): Revenues: 9,636 (+9.1%); Operating Expenses: 7,719 (+7.6%); Non-GAAP EBITDA: 1,956 (+14.1%); Net Income: 527 (+24.3%); EPS: 1.19 (+29.3%); CF Ops: 1,627 (+32.7%); Quick Assets: 566 (+36.7%).
- Admissions: 458,000 (+5.5%); Equivalent Admissions: 760,200 (+6.1%); Revenue Per Equivalent Admission: 12,676 (+2.7%); Inpatient Revenue Per Admission: 12,461 (+2.8%); Patient Days: 2,216,700 (+6.3%); Equivalent Patient Days: 3,679,000 (+7.0%); Inpatient Surgery Cases: 132,600 (+3.0%); Outpatient Surgery Cases: 233,400 (+0.2%); ER Visits: 1,949,200 (+11.1%).
- 2015 Guidance: Revenues: $38.5B - 39.5B; Non-GAAP EBITDA: $7.35B - 7.65B; Non-GAAP EPS: $4.55 - 4.95; CAPEX: ~$2.4B.
Tue, Feb. 3, 8:33 AM
Mon, Feb. 2, 5:30 PM
Mon, Feb. 2, 1:33 PM
Fri, Jan. 23, 5:31 PM
Tue, Jan. 13, 10:27 AM| Comment!
Fri, Jan. 9, 5:31 PM
- HCA +2.6% AH after raising guidance for FY 2014 EBITDA to ~$7.4B from an earlier range of $7.25B-$7.35B.
- HCA says Q4 results will include a $68M increase in Medicaid revenues related to the reversal of the Texas Medicaid Waiver Program adjustment that had been recorded in Q3.
- Says same-facility admissions rose ~5% in Q4, while same-facility emergency room visits rose ~10.5%.
Dec. 2, 2014, 10:22 AM
- Based on data collected from the analysis of medical records, the Centers for Medicare and Medicaid Services (CMS) report that U.S. hospitals saved 50,000 lives in 2013 by making 17% fewer medical mistakes. The improvement includes a 9% decline in hospital-acquired conditions such as infections, bedsores and pneumonia.
- Secretary of Health and Human Services (HHS) Sylvia Burwell is scheduled to announce the findings today at the CMS Healthcare Quality Conference in Baltimore.
- In 1999, the Institute of Medicine estimated that almost 100K people die each year from medical mistakes and poor quality of care. In 2010, the HHS inspector general estimated that poor care contributed to the deaths of 180K Medicare patients.
- One motivator for the improvement is a change in the way Medicare pays hospitals. Under updated rules, CMS reduces the reimbursement rate for hospitals that readmit too many patients within 30 days of discharge, an indicator of substandard care the first time.
- ETFs: IRY, IXJ,
- Hospital tickers: (HUM)(HCA +0.2%)(UHS -0.3%)(SEM +0.8%)(LPNT +0.4%)(CYH +0.3%)(SSY -0.2%)
Oct. 28, 2014, 3:54 PM| Comment!
Oct. 28, 2014, 11:56 AM
- HCA Holdings (HCA -0.5%) Q3 results ($M): Revenues: 9,220 (9.0%); Operating Expenses: 8,291 (+6.9%); Net Income: 611 (+30.8%); EPS: 1.16 (+46.8%); Quick Assets: 515 (-21.7%); CF Ops (9 mo.); 2,821 (+15.0%).
- Number of hospitals: 165 (+1.9%); licensed beds: 43,241 (+2.9%); admissions: 449,400 (+3.9%); patient days: 2.15M (+5.8%); equivalent occupancy: 90.5% (+4.5%).
- 2014 Guidance: Revenues: $36.5B - 37.0B from $36.0B - 36.5B; non-GAAP EBITDA: $7.25B - 7.35B from $7.00B - 7.15B; non-GAAP EPS: $4.40 - 4.60 from $4.00 - 4.25; capex: ~$2.2B (unch).
HCA vs. ETF Alternatives
Other News & PR